Cargando…
De‐risking Clinical Trials: The BIAL Phase I Trial in Foresight
Autores principales: | Cohen, Adam F., van Smeden, Jeroen, Webb, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303912/ https://www.ncbi.nlm.nih.gov/pubmed/34962650 http://dx.doi.org/10.1002/cpt.2498 |
Ejemplares similares
-
Foresight science in conservation: Tools, barriers, and mainstreaming opportunities
por: Ednie, Gabrielle, et al.
Publicado: (2022) -
μBialSim: Constraint-Based Dynamic Simulation of Complex Microbiomes
por: Popp, Denny, et al.
Publicado: (2020) -
In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2023) -
Students’ guide to documentation in clinical trials
por: Heck, Johannes, et al.
Publicado: (2022) -
20/20 foresight for 2020?
por: Woolley, Adam T.
Publicado: (2020)